Due To Gas Prices, US Retail Sales Increased By 0.3% in August
Unexpectedly, August saw a 0.3 per cent increase in U.S. retail sales as consumers relaxed some of their recent restraints on other areas of spending...
Tag : market
THG’s Share Price Plummets to Fresh All-Time Low
Following the release of subpar earnings and a profit warning, the share price of THG has dropped to new lows.After releasing a poor set of...
Wipro Share Price up 1.46 Per Cent, Today
Shares of Wipro were up 1.46 per cent on BSE, roughly on par with the broader Mumbai market. Wipro shares traded 1.46 per cent higher at...
Cadila gets USFDA approval to market 4 generic products
Zydus Cadila has received final approvals from the US health regulator, to market four generic products in America. The approvals received are for Olanzapine tablets in strengths...
Cadila Healthcare receives USFDA nod to market Nifedipine tablets
Cadila Healthcare has received final approval to market Nifedipine extended-release tablets USP in the strengths of 30 mg, 60 mg, and 90 mg, from the US...
Aurobindo Pharma gets USFDA approval to market Ibuprofen capsules
Aurobindo Pharma has received final approval to manufacture and market Ibuprofen capsules. The approval has been received from the US health regulator. In a BSE filing the...
Zydus Cadila gets USFDA approval to market Nystatin ointment
Zydus Cadila receives final approval to market Nystatin ointment and Omeprazoleand Sodium Bicarbonate capsule, from the US health regulator. The company received approval to market Nystatin Ointment USP,...
Cadila gets USFDA approval to market drug for prostate condition
Zydus Cadila has received final approval from the US health regulator to market Dutasteride and Tamsulosin Hydrochloride capsules. It is used to treat symptoms of Benign...
Zydus Cadila gets USFDA approval to market 2 drugs
Zydus Cadila has received final approval to market two drugs, from the US health regulator. The company stated that, it has received approval to market Methylprednisolone tablets USP...
Lupin gets USFDA approval to market Tetrabenazine tablets
Lupin has received final approval to market its Tetrabenazine tablets, from the US health regulator. It is used for treating involuntary movements associated with Huntington’s disease....